Lawrence G Hamel Insider Trading
Get free email notifications about insider trading for Lawrence G Hamel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Lawrence G Hamel. Lawrence G Hamel is a Chief Development Officer in ACELRX PHARMACEUTICALS INC ($ACRX).
Address: C/O ACELRX PHARMACEUTICALS, INC. 575 CHESAPEAKE DRIVE REDWOOD CITY 94063 CA
Companies in which Lawrence G Hamel is an Insider
ACELRX PHARMACEUTICALS INC
Trading Symbol: ACRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Lawrence G Hamel: Chief Development Officer
Holdings: 133,382 shares
Current Value: $400,146
Latest Transaction: Feb 07 2020
$ACRX Market Capitalization: $131.47M
$ACRX Previous Close: $3.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Lawrence G Hamel
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 07 2020 | ACRX | ACELRX PHARMACEUTI ... | Hamel Lawrence G | Chief Development O ... | Option Exercise | A | 1.72 | 100,000 | 172,000 | 100,000 | |
Feb 07 2020 | ACRX | ACELRX PHARMACEUTI ... | Hamel Lawrence G | Chief Development O ... | Grant | A | 0.00 | 50,000 | 0 | 133,382 | 83.4 K to 133.4 K (+59.96 %) |
Nov 04 2019 | ACRX | ACELRX PHARMACEUTI ... | Hamel Lawrence G | Chief Development O ... | Option Exercise | A | 2.23 | 26,125 | 58,128 | 52,250 | |
Feb 13 2019 | ACRX | ACELRX PHARMACEUTI ... | Hamel Lawrence G | Chief Development O ... | Option Exercise | A | 2.51 | 100,000 | 251,000 | 100,000 | |
Feb 13 2019 | ACRX | ACELRX PHARMACEUTI ... | Hamel Lawrence G | Chief Development O ... | Grant | A | 0.00 | 50,000 | 0 | 74,371 | 24.4 K to 74.4 K (+205.16 %) |
Nov 05 2018 | ACRX | ACELRX PHARMACEUTI ... | Hamel Lawrence G | Chief Development O ... | Option Exercise | D | 2.23 | 5,000 | 11,125 | 21,125 | |
Nov 05 2018 | ACRX | ACELRX PHARMACEUTI ... | Hamel Lawrence G | Chief Development O ... | Option Exercise | A | 2.23 | 26,125 | 58,128 | 26,125 |